Immunogenicity and safety of third, fourth and subsequent COVID-19 vaccine doses in recipients of hematopoietic cell transplantation and cellular therapy
{{output}}
Background: Recipients of hematopoietic cell transplantation (HCT) and immune effector cellular (IEC) therapies are particularly vulnerable to infectious complications after treatment. Given the ongoing transmission of SARS-CoV-2... ...
